Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Costs of predicting IDDM

J Hahl1, T Simell, J Ilonen

  • 1Department of Economics, Turku School of Economics and Business Administration, Finland.

Diabetologia
|March 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1.

Nature communications·2021
Same author

Circulating β cell-specific CD8<sup>+</sup> T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes.

Clinical and experimental immunology·2019
Same author

Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.

Pediatric diabetes·2017
Same author

Serum carotenoid and tocopherol concentrations and risk of asthma in childhood: a nested case-control study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.

HLA·2017
Same author

A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.

Diabetes/metabolism research and reviews·2016

A genetically targeted strategy for predicting and preventing insulin-dependent diabetes mellitus (IDDM) is more cost-effective than a pure immunological approach. This method saves money by identifying at-risk individuals earlier, reducing the need for repeated testing.

Area of Science:

  • Endocrinology
  • Immunology
  • Health Economics

Background:

  • Insulin-dependent diabetes mellitus (IDDM) is a multifactorial autoimmune disease with global prevention programs.
  • Predicting and preventing IDDM requires identifying at-risk individuals efficiently.

Purpose of the Study:

  • To compare the cost-effectiveness of different prediction strategies for IDDM.
  • To analyze direct costs from a healthcare provider's perspective in the Finnish DIPP project.

Main Methods:

  • Cost analysis of a genetically targeted strategy versus a pure immunological strategy.
  • Genetic susceptibility assessment followed by autoimmune marker monitoring in a restricted population.
  • Repeated autoimmune marker analysis in the entire population for the immunological strategy.

Related Experiment Videos

Main Results:

  • The genetically targeted strategy is cost-saving, especially in the long term.
  • 10-year direct costs per child: $245 (genetically targeted) vs. $733 (immunological).
  • Sensitivity analysis showed genetically targeted strategy costs ranging from $152-$241, and immunological from $430-$788.

Conclusions:

  • Genetically targeted IDDM prediction is significantly more cost-effective than the pure immunological strategy.
  • Reduced retesting frequency in the genetically targeted approach drives cost savings.
  • This strategy is crucial for efficient IDDM prevention programs.